Tatva Chintan Pharma Chem files Rs 450-crore IPO


Source: indiamedtoday.com indiamedtoday.com

Key Topics in this News Article:

News Snapshot:

IMT News Desk April 3, 2021 0 502 Proceeds from the issue will be used towards funding capital expenditure requirements for the expansion of the company’s Dahej manufacturing facility Speciality chemical manufacturing company Tatva Chintan Pharma Chem has filed preliminary papers with capital markets watchdog Sebi to raise Rs 450 crore through an initial share sale. The initial public offer (IPO) comprises fresh issuance of equity shares worth Rs 225 crore and an offer of sale to the tune of Rs 225 crore by existing promoters and shareholders, according to draft red herring prospectus (DRHP). Proceeds from the fresh issue...